Author:
Packer Milton,Anker Stefan D.,Butler Javed,Filippatos Gerasimos,Ferreira Joao Pedro,Pocock Stuart J.,Sattar Naveed,Brueckmann Martina,Jamal Waheed,Cotton Daniel,Iwata Tomoko,Zannad Faiez
Funder
Baylor University Medical Center
Subject
Cardiology and Cardiovascular Medicine
Reference40 articles.
1. Empagliflozin in heart failure: diuretic and cardiorenal effects;Griffin;Circulation,2020
2. Renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure: the RECEDE-CHF trial;Mordi;Circulation,2020
3. Effects of empagliflozin on renal sodium and glucose handling in patients with acute heart failure;Boorsma;Eur J Heart Fail,2020
4. Effects of dapagliflozin on volume status when added to renin-angiotensin system inhibitors;Eickhoff;J Clin Med,2019
5. Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis;Hallow;Diabetes Obes Metab,2018
Cited by
116 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献